Segments - Non-PVC IV Bags Market by Product (Single Chamber and Multi Chamber), Material (Ethylene Vinyl Acetate, Polypropylene, and Copolyester Ether), Application (Chemotherapy, Targeted Drug Delivery, Glucose Injection, Sodium Chloride Solution, Electrolyte Injection, Nutrient Injection, and Others) and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024 – 2032
The global non-PVC IV bags market size was USD 1.8 Billion in 2023 and is likely to reach USD 4.4 Billion by 2032, expanding at a CAGR of 10.7% during 2024–2032. The market growth is attributed to the Increasing need for the non-toxic materials and rising awareness and regulations on PVC.
Non-PVC IV bags are the intravenous bags made up of non-polyvinyl chloride film. These bags have low risk of contamination. The bags are better than the traditional PVC bags which often faced the problems of drug and container interaction. These bags are safer, lightweight, compatible, and convenient. The materials used to make the non-PVC IV bags are resistant to chemicals and heat.
PVC bags are associated with toxins ad it directly interacts with drugs, hence are hazardous for infant’s reproductive system. Non-PVC are currently used in several fields such as oncology and parenteral nutrition. It is made up of Ethylene-Vinyl Acetate (EVA) and Polypropylene (PP) without any plasticizers. Manufacturers are innovating ways to provide PVC and DEHP-free product lines. For instance,
Since 2019, B. Braun has spent USD 500 million for developing DHEP and PVC-free product lines.
Increasing need for the non-toxic materials and is driving the market. Moreover, the rising awareness and regulations on PVC is pushing the healthcare providers towards a safer alternative such as non-PVC IV bags. The environment friendly non-PVC materials have a significant advantage for sustainable medical practices.
Higher initial cost of non-PVC IV bags compared to the traditional PVC bags restraining the global market. Moreover, the material limitations in terms of durability, flexibility, and compatibility with certain drugs hindering the market. The production process for non-PVC IV bags is complex and require advanced technical expertise.
Developments in terms of technological innovations offers the improved performance and cost-effectiveness. These advancements offer a wider range of drug compatibility. Innovations in manufacturing process is reduces the production cost and increasing scalability. Moreover, the expansion of emerging markets and development in the countries is propelling the market.
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Non-PVC IV Bags Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017–2022 |
Forecast Period |
2024–2032 |
Segmentation |
Product (Single Chamber and Multi Chamber), Material (Ethylene Vinyl Acetate, Polypropylene, and Copolyester Ether), Application (Chemotherapy, Targeted Drug Delivery, Glucose Injection, Sodium Chloride Solution, Electrolyte Injection, Nutrient Injection, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
ANGIPLAST PVT. LTD; B. Braun Melsungen AG; Baxter; Fresenius Kabi AG; Jiangxi Sanxin Medtec Co., Ltd.; JW Life Science; Kraton Corporation; Pfizer, Inc. (Hospira); PolyCine GmbH; RENOLIT; Sealed Air; and Shanghai Solve Care Co Ltd. |
In terms of region, the global non-PVC IV bags market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominates the global market in 2023 owing to advanced healthcare infrastructure. High spend on healthcare by the regional population is propelling the regional market. Furthermore, the increasing adoption of advanced medical technologies is fueling the market in North America.
The market in Asia Pacific is projected to grow at a significant pace in the years to come owing to the increasing awareness about the benefits of non-PVC materials. Furthermore, the rising prevalence of chronic diseases is expected to fuel the segment during the forecast period. The substantial investments in healthcare facilities in countries such as India and China, is fueling the regional market.
Based on product, the non-PVC IV bags market is divided into single chamber and multi chamber. The single chamber segment held the largest share in the global market in 2023 owing to the increasing use of the single-chamber items. The single-use chambers offer the advantages such as the ease of storage, shipping, and recycling fueling the segment. The IV solutions such as drip bags, irrigation fluids, and sterile water are the factors for making the wide usage pf single-chamber containers.
The multi-chamber segment is anticipated to grow at a substantial CAGR during the forecast period owing to its material with which they are prepared. The multi-chamber products are made from materials commonly used in healthcare, such as non-PVC film with fast seal and simple peel-off properties.
On the basis of material, the global market is segregated into ethylene vinyl acetate, polypropylene, copolyester ether. The polypropylene segment is anticipated to register a considerable CAGR in over the predicted period due to its excellence on chemical resistance. The polypropylene is highly preferred for its durability. Furthermore, the cost effectiveness of polypropylene is boosting the segment significantly.
The ethylene vinyl acetate segment is projected to register a robust growth rate during the assessment years owing to its flexibility. Moreover, the clarity of EVA makes it a popular alternative to PVC in medical application driving the segment. The EVA offers a superior flexibility and transparency, making it an ideal choice for the high-quality non-PVC IV bags.
On the basis of application, the non-PVC IV bags market is segmented into chemotherapy, targeted drug delivery, glucose injection, sodium chloride solution, electrolyte injection, nutrient injection, and others. The chemotherapy segment registers a robust growth rate in 2023 owing to the increasing prevalence of cancer. The rising demand for chemotherapy and it being the most preferable option in treating the cancer is driving the segment.
The nutrient injection segment is expected to expand at a significant growth rate over the projection period. The nutrition injection is increasingly been needed in the parenteral nutrition in hospital and clinics fueling the market.
The non-PVC IV bags market has been segmented on the basis of
Key players competing in the global non-PVC IV bags market are ANGIPLAST PVT. LTD; B. Braun Melsungen AG; Baxter; Fresenius Kabi AG; Jiangxi Sanxin Medtec Co., Ltd.; JW Life Science; Kraton Corporation; Pfizer, Inc. (Hospira); PolyCine GmbH; RENOLIT; Sealed Air; and Shanghai Solve Care Co Ltd.
These players utilize several development strategies, such as product launches and acquisitions, to boost their global presence. For instance,
In June 2022, Gufic Biosciences announced the development of high-quality Dual Chamber bags made up of polypropylene (DEHP free) and peelable aluminum foil allows the storage of unstable drugs, needs reconstitution just before the administration to the patient.